Clinical and Translational Oncology

, Volume 13, Issue 5, pp 328–334

Management of lung cancer-associated anaemia: the Spanish Lung Cancer Anaemia Survey (SLCAS)

  • Pere Gascón
  • José Almenárez
  • Ángel Artal
  • Carlos Camps
  • José Luis Fírvida
  • Pilar Garrido
  • José Luis González Larriba
  • Joaquín Montalar
Research Articles

DOI: 10.1007/s12094-011-0662-5

Cite this article as:
Gascón, P., Almenárez, J., Artal, Á. et al. Clin Transl Oncol (2011) 13: 328. doi:10.1007/s12094-011-0662-5

Abstract

Background

The purpose of the Spanish Lung Cancer Anaemia Survey (SLCAS) was to thoroughly investigate lung cancer-associated anaemia management, and describe the profile of lung cancer patients in relation to anaemia incidence and tumour type in Spain.

Patients and methods

This survey collected data from 1089 randomly recruited patients gathered by 50 Spanish physicians at 38 sites. In addition, a qualitative assay was performed through 16 one-to-one and 2 one-to-two interviews, and a discussion group of 4 cancer specialists participating in the survey.

Results

Lung cancer patients undergoing chemotherapy treatment had haemoglobin (Hb) levels <12.0 g/dl in 58.0% of the cases, in contrast to 39.0% of patients receiving no chemotherapy. Anaemia was treated in 53.0% of patients with Hb<12 g/dl (45.0% epoetin, 3.9% transfusion, 4.1% iron). Mean Hb level trigger was 9.7 g/dl for administration of epoetin and 8.2 g/dl for blood transfusion.

Conclusions

SLCAS reveals a significant change in the management of anaemia and clinical practice pattern in the use of erythropoiesis-stimulating agents (45.0% vs. 18.0%) and much less use of blood transfusions (3.9% vs. 15.0%) since the European Cancer Anaemia Survey performed five years ago.

Keywords

AnaemiaChemotherapyErythropoiesis-stimulating agentsLung cancerQuality of life

Copyright information

© Feseo 2011

Authors and Affiliations

  • Pere Gascón
    • 1
    • 2
  • José Almenárez
    • 3
  • Ángel Artal
    • 4
  • Carlos Camps
    • 5
  • José Luis Fírvida
    • 6
  • Pilar Garrido
    • 7
  • José Luis González Larriba
    • 8
  • Joaquín Montalar
    • 9
  1. 1.Department of Medical OncologyHospital ClínicBarcelonaSpain
  2. 2.ONVIDA GroupBarcelonaSpain
  3. 3.Hospital Universitario Insular de Gran CanariaGran CanariaSpain
  4. 4.Hospital Universitario Miguel ServetZaragozaSpain
  5. 5.Hospital General de ValenciaValenciaSpain
  6. 6.Complejo Hospitalario de OurenseOurenseSpain
  7. 7.Hospital Ramón y CajalMadridSpain
  8. 8.Larriba Hospital Clínico San CarlosMadridSpain
  9. 9.Hospital Universitario La FeValenciaSpain